SAHAREK JOHN P.
SEC insider (Form 3/4/5 filer). CIK 0001632091. CEO of ImprimisRx at HARROW, INC. (HROW). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2025. Located in NASHVILLE, TN.
Companies SAHAREK JOHN P. has filed insider reports for
- HARROW, INC. (HROW): Officer, CEO of ImprimisRx
SAHAREK JOHN P.
CIK: 0001632091
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HROW
HARROW, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 7, 2025HROW
HARROW, INC.
Tax PaymentDirect109.5K shares at avg. $23.09$2.5M - Apr 3, 2025HROW
HARROW, INC.
ExerciseDirect277.2K shares- - Sep 11, 2024HROW
HARROW, INC.
ExerciseDirect90K shares at avg. $7.37$663K - Sep 11, 2024HROW
HARROW, INC.
Tax PaymentDirect45.1K shares at avg. $41.37$1.9M
1-4 of 4 transactions